3Muller G,Hant D,Punter J,et al. Differential interact in glimepiride with B cell sulfonylurea receptor. Biochim Biophys Acta, 2004, 1191(2) :267-277. 被引量：1
二级参考文献18
1Kobayashi T, Maruyama T, Shimada A, et al. Insulin intervention to preserve beta cells in slowly progressive insulin-dependent(type 1)diabetes mellitus. Ann N Y Acad Sci, 2002,958( ):117 被引量：1
2Clark R B, Bishop-Bailey D, Estrada-Hernandez T, et al. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. J Immunol,2000,164(3):1364 被引量：1
3Beales P E, Pozzilli P. Thiazolidinediones for the prevention of diabetes in the non-obese diabetic(NOD)mouse: implications for human type 1 diabetes. Diabetes Metab Res Rev, 2002,18(2):114 被引量：1
4Isomaa B. A Major health hazard: the metabolic syndrome. Life Sci, 2003, 73(19):2395 被引量：1
5Vauhkonen I, Niskanen L, Knip M, et al. Impaired insulin secreation in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults. Diabetologia, 2000:43(1):69 被引量：1
6World Health Organization. Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications: Report of WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, Switzerland: World Health Organization, 1999. 被引量：1
7Lohmann T, Kellner K, Verlohren H J, et al. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults(LADA). Diabetologia, 2001, 44(8):1005 被引量：1
8Behme M T, Dupre J, Harris S B, et al. Insulin resistance in latent autoimmune diabetes of adulthood. Ann N Y Acad Sci, 2003,1005:374 被引量：1
9Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001,24(4):683 被引量：1
10Karvonen M, Viik-Kajander M, Moltchanova E, et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care, 2000,23(10):1516 被引量：1
